Archive - February 2018
CMS approves Indiana’s Medicaid work-requirement waiver
Merck expects a flat tax rate in 2018 as peers see benefit from reform
Stage 2 entries up by 40% – Clinical Researcher of the Year – The Americas
Addressing the Security Challenges Facing Life Sciences and Healthcare Companies
Amgen sinks after Q4 earnings miss despite tax benefits and plan for U.S. plant
PharmaTimes International Clinical Researcher of the Year: Entries close on a high
FiercePharmaAsia—Lantus biosimilar, Takeda’s Zika vaccine, Celltrion warning letter
Weak Vaccine Making Flu Season Even Tougher, CDC Says